A research report in the offing might be triggering advanced client buying. Nothing illegal in that. Based on my own understanding of the distribution progress and the opportunities unfolding I'd expect a 12 month target of around $1.30 and a two year target share price of over $2.00. Of course the strategic advantage to a large multi national US based speciality chemicals company could justify many times that, although $10 is a wonderful but fanciful price target in under a 5 year horizon IMO. It's the sheer uniqueness of their offering that must take it mainstream,
I'd like to see a run to back over a $1.00 over the coming two weeks, so inclusion in the ASX 300 occurs. It justified.
AJX Price at posting:
72.0¢ Sentiment: Buy Disclosure: Held
